Plasma-derived medicinal products: demand and clinical use

被引：14
|
作者：
Grazzini, Giuliano [1 ]
Mannucci, Pier Mannuccio [2 ]
Oleari, Fabrizio [3 ]
机构：
[1] Italian Natl Blood Ctr, Natl Inst Hlth, I-00162 Rome, Italy
[2] IRCCS Ca Granda Fdn Maggiore Policlin Hosp, Sci Direct, Milan, Italy
[3] Natl Inst Hlth, Rome, Italy
来源：
BLOOD TRANSFUSION | 2013年 / 11卷
关键词：
ITALIAN DEMAND; POLYVALENT IMMUNOGLOBULINS; PROTHROMBIN COMPLEX; SELF-SUFFICIENCY; FACTOR-VIII; FACTOR-IX; FRACTIONATION; SYSTEM;
D O I：
10.2450/2013.002s
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：S2 / S5
页数：4
相关论文
共 50 条
  • [21] Clinical outcomes from the evolution in quality of plasma-derived products
    Dash, C.
    VOX SANGUINIS, 2006, 91 : 19 - 19
  • [22] Plasma-derived products: Biological therapeutic products
    Follea, G
    Cazenave, JP
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 1997, 4 (02) : 227 - 240
  • [23] Inactivation and Removal of Chikungunya Virus and Mayaro Virus from Plasma-derived Medicinal Products
    Yue, Constanze
    Teitz, Sebastian
    Miyabashi, Tomoyuki
    Boller, Klaus
    Lewis-Ximenez, Lia Laura
    Baylis, Sally A.
    Bluemel, Johannes
    VIRUSES-BASEL, 2019, 11 (03):
  • [24] Overview of regulatory frameworks on the national lot release of plasma-derived medicinal products in Korea
    Seong, Su Kyoung
    Kim, Young Hoon
    Choi, Youngju
    Koh, Hyun Jung
    Kim, Seong Jae
    Kim, Myoung Jun
    Choi, Chan Woong
    BIOLOGICALS, 2024, 86
  • [25] An industry perspective on plasma-derived products
    von Hoegen, I
    PDA/EMEA EUROPEAN VIRUS SAFETY FORUM, 2004, 118 : 31 - 35
  • [26] Nanofiltration of plasma-derived biopharmaceutical products
    Burnouf, T
    Radosevich, M
    HAEMOPHILIA, 2003, 9 (01) : 24 - 37
  • [27] The safety of plasma-derived products in Australia
    Guirguis, Andrew
    Wood, Erica
    AUSTRALIAN PRESCRIBER, 2010, 33 (03) : 76 - 79
  • [28] HUMAN PLASMA FRACTIONATION AND THE IMPACT OF NEW TECHNOLOGIES ON THE USE AND QUALITY OF PLASMA-DERIVED PRODUCTS
    BRODNIEWICZPROBA, T
    BLOOD REVIEWS, 1991, 5 (04) : 245 - 257
  • [29] Orthopox viruses and the safety margins of solvent-detergent treated plasma-derived medicinal products
    Kindermann, Johanna
    Karbiener, Michael
    Kreil, Thomas R.
    TRANSFUSION, 2022, 62 (12) : 2454 - 2457
  • [30] Effective coronavirus reduction by various production steps during the manufacture of plasma-derived medicinal products
    Schraeder, Tobias
    Koch, Julia
    Ross, Rachael
    Schaefer, Wolfram
    Keiner, Bjoern
    Roth, Nathan J.
    Widmer, Eleonora
    TRANSFUSION, 2020, 60 (06) : 1334 - 1335
12345